We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Oruba Presents State-of-the-Art Self-Operating Uroflowmeters

By LabMedica International staff writers
Posted on 15 Nov 2023
Print article
Image: Oruba Technology is showcasing the future of urology at MEDICA 2023 (Photo courtesy of Oruba)
Image: Oruba Technology is showcasing the future of urology at MEDICA 2023 (Photo courtesy of Oruba)

Oruba Technology & Innovation (Langenfeld, Germany) is demonstrating its state-of-the-art self-operating uroflowmeters at MEDICA 2023.

Oruba is showcasing Oruflow, the world’s first self-operating uroflowmeter. As a point-of-care diagnostic device, it eases and accelerates the uroflowmetry process in a hygienic and comfortable atmosphere. The self-cleaning and hygienic point-of-care solution has revolutionized the process of uroflowmetry, making it a crucial part of every hospital and urology clinic. The self-operating uroflowmeter can be operated in easy steps. The patient first has to scan the hospital barcode to start the examination. The on-board screen helps the patients and guides them during the examination. Oruba Oruflow measures the test parameters and prepares the report. The patient then uses the hospital barcode to let Oruba Oruflow save the examination report into the hospital information system automatically. The patient can receive the results of the examination in seconds without any operator guidance.

As soon as the urination finishes, Oruba Oruflow prints the results out and cleans itself automatically. The patient can go to the doctor directly and the device gets ready for the next examination in one minute. Oruba Oruflow does not require an operator or nurse guidance and the patient does the test in an actual restroom comfort. Oruba Oruflow technology creates a hygienic and relaxed clinical atmosphere and prevents the unpleasant smell and dirt problem. Oruba Oruflow’s high-developed IoT technology and auto-notification system allows it to provide online technical service and solve the problem in minutes. The yearly maintenance and software upgrades are done from the Oruba HQ

Related Links:
Oruba Technology & Innovation 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.